| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 580 | 2023 |
| Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US J Sun, Q Zheng, V Madhira, AL Olex, AJ Anzalone, A Vinson, JA Singh, ... JAMA internal medicine 182 (2), 153-162, 2022 | 273 | 2022 |
| Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19 CT Bramante, JD Huling, CJ Tignanelli, JB Buse, DM Liebovitz, ... New England Journal of Medicine 387 (7), 599-610, 2022 | 256 | 2022 |
| Obesity management in adults: a review A Elmaleh-Sachs, JL Schwartz, CT Bramante, JM Nicklas, KA Gudzune, ... Jama 330 (20), 2000-2015, 2023 | 223 | 2023 |
| Characterizing long COVID: deep phenotype of a complex condition RR Deer, MA Rock, N Vasilevsky, L Carmody, H Rando, AJ Anzalone, ... EBioMedicine 74, 2021 | 198 | 2021 |
| Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis CT Bramante, NE Ingraham, TA Murray, S Marmor, S Hovertsen, ... The Lancet Healthy Longevity 2 (1), e34-e41, 2021 | 197 | 2021 |
| Identifying who has long COVID in the USA: a machine learning approach using N3C data ER Pfaff, AT Girvin, TD Bennett, A Bhatia, IM Brooks, RR Deer, ... The Lancet Digital Health 4 (7), e532-e541, 2022 | 169 | 2022 |
| Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial CT Bramante, JB Buse, DM Liebovitz, JM Nicklas, MA Puskarich, K Cohen, ... The Lancet Infectious Diseases 23 (10), 1119-1129, 2023 | 167 | 2023 |
| Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information HM Rando, TD Bennett, JB Byrd, C Bramante, TJ Callahan, CG Chute, ... MedRxiv, 2021 | 162 | 2021 |
| Observational study of metformin and risk of mortality in patients hospitalized with Covid-19 CT Bramante, NE Ingraham, TA Murray, S Marmor, S Hovertsen, ... MedRxiv, 2020 | 124 | 2020 |
| Polysorbate 80 Inhibition of Pseudomonas aeruginosa Biofilm Formation and Its Cleavage by the Secreted Lipase LipA CM Toutain-Kidd, SC Kadivar, CT Bramante, SA Bobin, ME Zegans Antimicrobial agents and chemotherapy 53 (1), 136-145, 2009 | 106 | 2009 |
| Treatment of obesity in patients with diabetes CT Bramante, CJ Lee, KA Gudzune Diabetes Spectrum 30 (4), 237-243, 2017 | 101 | 2017 |
| Effect of ivermectin vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial S Naggie, DR Boulware, CJ Lindsell, TG Stewart, N Gentile, S Collins, ... JAMA 328 (16), 1595-1603, 2022 | 88 | 2022 |
| mTOR inhibition in COVID‐19: A commentary and review of efficacy in RNA viruses BS Karam, RS Morris, CT Bramante, M Puskarich, EJ Zolfaghari, ... Journal of medical virology 93 (4), 1843-1846, 2021 | 84 | 2021 |
| Effect of higher-dose ivermectin for 6 days vs placebo on time to sustained recovery in outpatients with COVID-19: a randomized clinical trial S Naggie, DR Boulware, CJ Lindsell, TG Stewart, AJ Slandzicki, SC Lim, ... Jama 329 (11), 888-897, 2023 | 64 | 2023 |
| The most undertreated chronic disease: addressing obesity in primary care settings S Tucker, C Bramante, M Conroy, A Fitch, A Gilden, S Wittleder, M Jay Current obesity reports 10, 396-408, 2021 | 61 | 2021 |
| Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial MW McCarthy, S Naggie, DR Boulware, CJ Lindsell, TG Stewart, ... Jama 329 (4), 296-305, 2023 | 59 | 2023 |
| Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19 CT Bramante, CJ Tignanelli, N Dutta, E Jones, L Tamaritz, J Clark, ... MedRxiv, 2020 | 58 | 2020 |
| Diagnosis of ocular tuberculosis: a role for new testing modalities? CT Bramante, EA Talbot, SR Rathinam, R Stevens, ME Zegans International ophthalmology clinics 47 (3), 45-62, 2007 | 58 | 2007 |
| Association of early aspirin use with in-hospital mortality in patients with moderate COVID-19 JH Chow, A Rahnavard, M Gomberg-Maitland, R Chatterjee, P Patodi, ... JAMA network open 5 (3), e223890-e223890, 2022 | 55 | 2022 |
Clare LeeEli Lilly and CompanyE-mail megerősítve itt: lilly.com